Vaccination against the respiratory syncytial virus
Conditions
Interventions
Group 1: Standard clarification (treatment as usual): Presentation as a video recording of a medical clarification consultation in a rational and sober style. Duration of the video approx. 3:15 minute
Sponsors
Universitätsklinikum Essen
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: Sufficient knowledge of German
Exclusion criteria
Exclusion criteria: Lack of ability to provide consent, severe allergic reactions in the past, presence of an acute infection, patients with a blood clotting disorder, lack of informed consent, inability to participate in the study in the opinion of the study physicians (e.g. acute depression, psychosis)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| symptom expectations, symptom-related anxieties, self-reported physical and psychological sickness symptoms (physical symptoms, negative mood, anxiety, fatigue) using standardised questionnaires. On day 1, the patient is vaccinated in the morning and receives the baseline questionnaires. The first data collection then takes place at 3 p.m., at 8 p.m. in the evening, and on day 2 at 8 a.m., 3 p.m. and 8 p.m., and data collection continues in this manner up to and including day 3. | — |
Secondary
| Measure | Time frame |
|---|---|
| Physiological parameters: blood pressure, heart rate, body temperature (day 1, day 2, day 3 at 8 a.m., 3 p.m. and 8 p.m. respectively) | — |
Countries
Germany
Contacts
Public ContactHana Rohn
Universitätsklinikum Essen
Outcome results
None listed